ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP5095	Overview of proinflammatory and profibrotic mediators	38/676	73/5963	7.79250067518198e-18	3.64689031598517e-15	3.10059500549346e-15	6356/6357/6362/6347/6364/6368/6369/6348/6351/9560/6355/1437/1440/6376/2919/3627/6373/284340/2920/2921/6374/6372/4283/3458/3589/3605/3552/3553/3557/11009/90865/3569/4312/4314/5008/5196/6696/8741	38
WP5055	Burn wound healing	43/676	93/5963	1.63015603297461e-17	3.81456511716059e-15	3.24315252876001e-15	8038/6347/57124/1139/1277/1278/2919/3579/1634/2200/2335/10468/3082/3383/3552/3553/3569/3624/3791/3853/23643/407024/4312/4322/4313/79148/4314/100463486/64332/64127/5159/6282/6280/8796/871/6423/6678/7042/7043/7076/7097/51311/3371	43
WP2806	Complement system	36/676	75/5963	1.68673901369e-15	2.6313128613564e-13	2.23714858657832e-13	133/715/716/717/719/720/722/728/27202/729/1604/22918/629/3075/3426/5199/10332/1380/1634/2214/2219/2357/2769/3383/3673/3687/3690/3915/5648/5329/5806/6401/6403/710/6696/7097	36
WP558	Complement and coagulation cascades	27/676	48/5963	3.98634947639318e-14	4.66402888738002e-12	3.96536868967532e-12	712/713/715/716/717/719/721/728/729/1604/629/3075/3426/1380/2149/2153/2155/3827/5648/5327/5328/5329/5104/5054/710/7056/7450	27
WP5115	Network map of SARS-CoV-2 signaling pathway	56/676	190/5963	3.90713021880004e-12	3.65707388479684e-10	3.10925310043456e-10	350/8542/684/715/716/6356/6347/6364/6348/6351/6355/9332/1051/629/3075/3426/5199/1294/1514/2919/3627/2920/2921/6374/6372/4283/3577/3579/84985/2247/2335/3091/10964/2537/8519/10410/3458/3605/8807/3552/3553/90865/3569/3699/116844/64386/114548/5196/5743/6288/6289/6403/5104/5054/6772/7018	56
WP455	GPCRs, class A rhodopsin-like	39/676	118/5963	1.95379151036961e-10	1.5239573780883e-08	1.29567226477143e-08	134/147/187/719/27202/1230/729230/1232/1237/10803/3577/3579/1909/2149/2151/9002/2867/2357/2358/2359/54328/2842/2850/2861/2828/8111/8843/3274/64106/4886/4887/5540/53829/9934/5031/5724/5737/5739/56670	39
WP2911	miRNA targets in ECM and membrane receptors	15/676	22/5963	4.51473742236135e-10	3.01842444809302e-08	2.56627179797382e-08	1278/1281/1282/1284/1289/1290/50509/1291/1292/1293/2335/22801/3910/3915/7058	15
WP3624	Lung fibrosis	23/676	52/5963	1.79469365315306e-09	1.04989578709454e-07	8.92623948541916e-08	6356/6347/6348/6351/729230/1232/1051/1437/1440/2920/2247/2252/26585/3082/3553/3569/4313/5155/5328/5806/6696/7015/7076	23
WP545	Complement activation	12/676	18/5963	3.99756140826746e-08	2.07873193229908e-06	1.76734293839193e-06	712/713/715/716/717/720/721/729/1604/629/5199/5648	12
WP5090	Complement system in neuronal development and plasticity	30/676	93/5963	4.74976088210501e-08	2.22288809282514e-06	1.8899048562481e-06	712/713/715/716/717/719/720/721/722/725/728/27202/729/1604/629/3075/3426/5199/10584/1380/6376/2219/8547/3458/3687/3690/5648/710/7042/7043	30
WP24	Peptide GPCRs	18/676	41/5963	1.24252780493944e-07	5.28639102465142e-06	4.49450249059432e-06	719/728/1230/729230/1232/1237/10803/3577/3579/1909/2357/2358/2359/4886/4887/5540/6869/7253	18
WP2865	IL1 and megakaryocytes in obesity	13/676	23/5963	1.7728197369055e-07	6.38336773373007e-06	5.42715475337374e-06	6347/1232/2149/3383/3458/3553/3554/114548/7941/6280/8991/7076/7097	13
WP2431	Spinal cord injury	30/676	98/5963	1.77315770381391e-07	6.38336773373007e-06	5.42715475337374e-06	199/301/63827/713/6347/729230/1280/1282/2919/3627/2920/2212/2697/3383/3458/3552/3553/3554/3569/10288/11025/4321/4843/9423/5743/6098/6403/6869/8741/1462	30
WP5088	Prostaglandin signaling	14/676	28/5963	4.45545527356175e-07	1.48939504859064e-05	1.26628728827544e-05	834/6347/6348/729230/2919/3627/4283/3458/3605/3552/3553/3569/114548/9536	14
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	57/676	265/5963	8.16955690466642e-07	2.54890175425592e-05	2.16708246313257e-05	284/285/1302/1277/1278/1280/1281/1282/1284/1289/1290/50509/1292/9586/1440/1441/1944/2149/2255/2247/2252/2321/2335/59345/2791/51764/3082/3091/3559/3563/22801/3673/3678/8516/3687/3690/3791/284217/3908/3910/3915/10319/4843/4846/5008/9180/5155/5159/5209/5228/6515/6696/7010/7058/3371/7143/7450	57
WP2848	Pluripotent stem cell differentiation pathway	15/676	34/5963	1.31993056373069e-06	3.86079689891228e-05	3.28245890190922e-05	3577/2255/2247/10468/3082/3589/3569/3624/10637/5155/6469/7018/7043/7472/7474	15
WP3967	miR-509-3p alteration of YAP1/ECM axis	10/676	17/5963	3.03878900151227e-06	7.91311522333555e-05	6.72774978502213e-05	1277/1281/1289/1909/2335/10082/6678/7004/7058/7291	10
WP129	Matrix metalloproteinases	12/676	24/5963	3.04350585512906e-06	7.91311522333555e-05	6.72774978502213e-05	4312/4319/4321/4322/4323/4327/4313/64386/79148/4314/4316/7076	12
WP619	Type II interferon signaling	14/676	34/5963	8.04537390814104e-06	0.000198170262579474	0.000168484838630322	3627/4283/2633/3383/2537/3458/3553/4843/5698/8651/9021/6688/6772/6890	14
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	20/676	63/5963	1.10392763822167e-05	0.000258319067343871	0.000219623498551469	6347/6348/6351/1437/2919/3627/6373/284340/2920/2921/6374/6372/4283/3579/84868/8519/3569/5196/6772/7020	20
WP2328	Allograft rejection	22/676	76/5963	2.11496028882113e-05	0.00046368588435421	0.000394226865240422	23743/712/713/717/720/721/729/1604/941/942/1289/6373/4283/50943/3002/3458/3605/3552/3553/3559/120892/6772	22
WP4172	PI3K-Akt signaling pathway	55/676	280/5963	2.26758027638565e-05	0.00046368588435421	0.000394226865240422	284/285/1277/1278/1280/1282/1284/1291/1292/1293/131873/9586/1440/1441/1944/2149/2255/2247/2252/2321/2335/59345/2791/51764/3082/3559/3563/3569/22801/3673/3678/8516/3690/3791/284217/3908/3910/3915/10319/4846/4915/5008/9180/5155/5159/5228/8503/10110/6696/7010/7058/7097/3371/7143/7450	55
WP4494	Selective expression of chemokine receptors during T-cell polarization	11/676	24/5963	2.27879814960403e-05	0.00046368588435421	0.000394226865240422	6348/6351/1230/729230/1232/1437/3458/3595/8809/7042/7043	11
WP4462	Platelet-mediated interactions with vascular and circulating cells	9/676	17/5963	3.07378732571292e-05	0.000599388528514019	0.000509601582947142	6347/3383/3553/5196/6401/6403/7042/7043/7097	9
WP4754	IL-18 signaling pathway	48/676	239/5963	4.23284144487674e-05	0.000792387918480925	0.000673690133121434	59/11096/6362/6347/6364/6348/6351/1051/9076/1277/1278/1281/2920/2921/2335/2523/338442/3383/3458/10068/8809/8807/3553/3559/3569/81618/4312/4322/4323/4313/4314/4688/4776/64332/4843/51299/7941/5743/5806/9021/6696/6869/7018/7052/7076/7127/79931/80149	48
WP5087	Malignant pleural mesothelioma	68/676	381/5963	6.49688420736101e-05	0.00116943915732498	0.000994260012300592	59/9510/284/285/834/6347/6351/29126/1009/1012/1014/1001/1003/1004/1282/1284/1437/1440/115908/2919/3627/6374/1944/2255/2247/2252/2321/2335/8061/11211/3082/3091/3620/3553/3569/3673/3690/3791/284217/3908/3910/3915/10319/26524/4323/4313/4314/114548/4915/5155/5159/5163/5228/5328/4920/6401/6422/6423/8140/64321/6678/6772/7004/7010/7015/7472/7474/25937	68
WP530	Cytokines and inflammatory response	9/676	19/5963	9.46288414647415e-05	0.00164023325205552	0.00139453029526988	1437/1440/2919/2920/3458/3589/3552/3553/3569	9
WP1533	Vitamin B12 metabolism	13/676	37/5963	0.000121282759148554	0.00202715468862583	0.00172349184053208	19/6347/2155/3383/3458/3553/3569/5327/6288/6289/5054/6648/6947	13
WP3617	Photodynamic therapy-induced NF-kB survival signaling	12/676	33/5963	0.00015167237047524	0.00244767825456594	0.0020810219978091	597/1437/2920/3383/3552/3553/3569/4312/4313/4314/5743/6401	12
WP4891	COVID-19 adverse outcome pathway	7/676	13/5963	0.000216502057341907	0.00331590166913175	0.00281918765391769	6347/6348/1440/3627/3553/3559/3569	7
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	18/676	65/5963	0.000219643059280095	0.00331590166913175	0.00281918765391769	947/2354/8456/94234/10468/2619/284110/3458/3488/5653/5650/8549/4488/22822/6275/6422/11005/7474	18
WP2877	Vitamin D receptor pathway	31/676	143/5963	0.000239501075270817	0.00350270322583569	0.00297800679119634	11096/147/768/634/9075/1543/1594/1555/1577/168002/1673/50486/3091/3488/9173/5653/3827/126364/639/5744/6273/6275/6279/6280/6422/219855/6696/79689/7042/7056/54210	31
WP2849	Hematopoietic stem cell differentiation	14/676	46/5963	0.000378009738213109	0.005360865378295	0.00455782076697146	947/1437/1440/2354/2624/3552/3553/3569/3690/4582/4778/861/6688/7068	14
WP474	Endochondral ossification	16/676	57/5963	0.000411628934614962	0.0055040668971372	0.00467957104614904	9510/9507/11096/249/1280/2247/2737/4256/4322/5327/5328/5744/871/6696/6772/7042	16
WP4808	Endochondral ossification with skeletal dysplasias	16/676	57/5963	0.000411628934614962	0.0055040668971372	0.00467957104614904	9510/9507/11096/249/1280/2247/2737/4256/4322/5327/5328/5744/871/6696/6772/7042	16
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	12/676	37/5963	0.000516130022833115	0.00670969029683049	0.00570459498920811	84674/834/50506/3553/4210/4671/58484/91662/114548/64127/639/8767	12
WP15	Selenium micronutrient network	16/676	59/5963	0.000627784342265708	0.00786498629654567	0.006686830454553	19/247/6347/2155/3383/3458/3553/3569/8942/5327/10549/5743/6288/6289/5054/6648	16
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	10/676	28/5963	0.000638609998437469	0.00786498629654567	0.006686830454553	6347/29126/941/942/3627/3559/8651/7042/7043/51311	10
WP5097	CCL18 signaling pathway	12/676	39/5963	0.000880168683697803	0.0105620242043736	0.00897985863529742	59/1237/1278/1437/2335/3091/4313/6615/6772/7004/7020/7291	12
WP306	Focal adhesion	35/676	183/5963	0.00116657708353808	0.0136489518773955	0.0116043720415103	87/1277/1278/1280/1282/1284/1290/50509/1292/2268/2321/2335/3055/3082/22801/3673/3678/8516/3690/3791/284217/3908/3910/3915/10319/5155/5159/5228/8503/399694/6696/7058/3371/7143/7450	35
WP5094	Orexin receptor pathway	24/676	112/5963	0.00139553250333896	0.0159294929649423	0.0135432936139185	2920/1846/2354/3091/9456/3383/3553/3569/3777/3908/4023/23764/7873/4322/4314/4846/64106/8013/5069/5163/861/6401/6696/3371	24
WP453	Inflammatory response pathway	9/676	26/5963	0.00153843283480384	0.0171425373020999	0.0145746268560363	941/942/1277/1278/1281/2335/3458/3559/3915	9
WP4823	Genes controlling nephrogenesis	10/676	32/5963	0.00206138857677535	0.0224355779983922	0.0190747829136128	2296/2737/3237/8516/3791/4868/5155/5159/6092/6469	10
WP716	Vitamin A and carotenoid metabolism	10/676	34/5963	0.00339794855794927	0.0361418164800058	0.0307278601651872	127/8854/83875/1381/1382/56603/4023/29881/116362/195814	10
WP1539	Angiogenesis	8/676	24/5963	0.00366744508627377	0.0381414288972472	0.0324279354996839	284/2247/2321/3091/3791/4846/5155/7010	8
WP272	Blood clotting cascade	6/676	15/5963	0.00421824643594145	0.0426662204831286	0.0362749242973968	2153/2155/5327/5328/5054/7450	6
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	10/676	35/5963	0.00428485547586975	0.0426662204831286	0.0362749242973968	284/285/597/3091/3485/4843/5743/5054/6515/7043	10
WP5092	Interactions of natural killer cells in pancreatic cancer	8/676	25/5963	0.0048679364804507	0.0474623806843943	0.0403526313511045	6347/6348/6351/1437/2214/2624/3002/3458	8
WP4496	Signal transduction through IL1R	9/676	31/5963	0.00590822107911508	0.0560847446731252	0.0476833861593372	3552/3553/3554/3556/3557/3569/11213/7042/7043	9
WP176	Folate metabolism	12/676	48/5963	0.0060308058778636	0.0560847446731252	0.0476833861593372	19/6347/2155/3383/3458/3553/3569/5327/6288/6289/5054/6648	12
WP4493	Cells and molecules involved in local acute inflammatory response 	6/676	16/5963	0.00611179909899441	0.0560847446731252	0.0476833861593372	729/3383/3552/3569/3827/6403	6
WP117	GPCRs, other	10/676	37/5963	0.00659889445405822	0.059390050086524	0.0504935648508908	27202/3577/3579/1909/2149/11245/53831/59340/53829/5737	10
WP5188	Retinol Metabolism	5/676	12/5963	0.00738889384388127	0.0652453267723856	0.0554717353125545	316/1543/1551/10170/195814	5
WP2197	Endothelin pathways	8/676	27/5963	0.00814483917185527	0.070588606156079	0.0600146044241967	10203/1909/2769/51764/4846/4886/23236/5739	8
WP4541	Hippo-Merlin signaling dysregulation	20/676	101/5963	0.0085517373280035	0.0720992207457287	0.061298932617826	1009/1012/1014/1001/1003/1004/3627/2321/22801/3673/3678/8516/3687/3690/3791/26524/4915/5159/7004/7010	20
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	7/676	22/5963	0.00862725718324959	0.0720992207457287	0.061298932617826	2919/2920/2247/3553/5155/6469/30812	7
WP3937	Microglia pathogen phagocytosis pathway	10/676	39/5963	0.00978106123723398	0.0789230458452673	0.0671005652935471	712/713/2207/2209/3055/4688/8503/54210/54209/7305	10
WP4329	miRNAs involvement in the immune response in sepsis	10/676	39/5963	0.00978106123723398	0.0789230458452673	0.0671005652935471	6348/6351/3002/3383/3552/3569/3934/407008/407024/51311	10
WP3929	Chemokine signaling pathway	27/676	152/5963	0.0112648623748877	0.0893551795160581	0.0759699906816688	6356/6364/6369/6348/6351/1230/729230/1232/1237/10803/6376/3627/6373/2921/6374/4283/3579/2268/59345/2791/51764/3055/5196/8503/23236/399694/6772	27
WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	12/676	52/5963	0.0117178279022614	0.0913990576376385	0.0777077008255226	1003/1277/1278/2321/3082/3791/4313/8829/91584/6615/7042/7043	12
WP5198	Inflammatory bowel disease signaling	9/676	35/5963	0.0137037026142281	0.105136603663258	0.0893873958270618	50943/3458/3595/8807/3552/3569/64127/6772/7097	9
WP98	Prostaglandin synthesis and regulation	10/676	41/5963	0.0140163148733041	0.105800570333973	0.0899519019033776	1645/301/308/1909/3290/9536/5737/5739/5743/6916	10
WP4239	Epithelial to mesenchymal transition in colorectal cancer	24/676	134/5963	0.0147890524460268	0.109259293650716	0.0928925168690297	9076/51208/9075/9073/1282/1284/2335/94234/11211/3091/3678/26524/4313/4854/4855/8828/8503/6615/6678/7042/7043/7291/7472/7474	24
WP12	Osteoclast signaling	5/676	14/5963	0.015408361925101	0.109259293650716	0.0928925168690297	1513/8111/3690/5155/6696	5
WP4210	Tryptophan catabolism leading to NAD+ production	5/676	14/5963	0.015408361925101	0.109259293650716	0.0928925168690297	3620/8942/10135/23057/6999	5
WP5063	FOXP3 in COVID-19	5/676	14/5963	0.015408361925101	0.109259293650716	0.0928925168690297	941/942/50943/3559/3569	5
WP5083	Neuroinflammation and glutamatergic signaling	21/676	115/5963	0.0177056300261508	0.123675147048337	0.105148910445955	816/1610/2247/2898/2906/116443/3458/3552/3553/3554/3569/80131/23236/29968/6507/6515/92745/9021/6772/7042/7043	21
WP2406	Cardiac progenitor differentiation	8/676	31/5963	0.0192754883034651	0.132660713617966	0.11278846097074	2247/2626/3624/3791/3084/4920/64321/7070	8
WP1992	Genes targeted by miRNAs in adipocytes	4/676	10/5963	0.019633867099729	0.133168837719901	0.113220469316515	2078/2697/9464/3759	4
WP727	Monoamine transport	6/676	21/5963	0.0253239179141765	0.169308479769065	0.143946480775319	273/3553/3554/3690/6853/6999	6
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	7/676	27/5963	0.0272491462534255	0.174669458357318	0.148504397793671	6347/2977/3553/3569/4312/4314/23657	7
WP465	Tryptophan metabolism	8/676	33/5963	0.0277205709154924	0.174669458357318	0.148504397793671	8854/316/1543/1545/9420/3620/8942/6999	8
WP3413	NOTCH1 regulation of endothelial cell calcification	5/676	16/5963	0.0277723381109018	0.174669458357318	0.148504397793671	249/813/2702/4256/5327	5
WP4478	LTF danger signal response pathway	5/676	16/5963	0.0277723381109018	0.174669458357318	0.148504397793671	3552/3553/3569/7097/54210	5
WP4707	Aspirin and miRNAs	4/676	11/5963	0.0281401790533712	0.174669458357318	0.148504397793671	283120/4846/5163/5743	4
WP5218	Extrafollicular B cell activation by SARS-CoV-2	13/676	65/5963	0.0283651257161456	0.174669458357318	0.148504397793671	57379/60468/720/941/1380/8519/3458/3569/3687/639/57823/8741/7494	13
WP4747	Netrin-UNC5B signaling pathway	10/676	46/5963	0.0304229329543811	0.184908215878576	0.157209414309721	249/6347/1003/1277/3383/3552/3791/9423/54538/6401	10
WP3941	Oxidative damage response	9/676	40/5963	0.0318330716809528	0.190998430085717	0.162387329222674	712/713/715/716/717/719/721/728/1380	9
WP4008	NO/cGMP/PKG mediated neuroprotection	8/676	34/5963	0.0327786809356196	0.194182565542658	0.165094488922907	816/1261/2906/2977/3458/3553/4843/4846	8
WP3287	Overview of nanoparticle effects	5/676	17/5963	0.0357792466240753	0.206724536050213	0.175757702714756	1001/1282/2335/3569/5743	5
WP4830	GDNF/RET signaling axis	5/676	17/5963	0.0357792466240753	0.206724536050213	0.175757702714756	2296/2737/26585/6092/64321	5
WP289	Myometrial relaxation and contraction pathways	22/676	131/5963	0.0371152677690248	0.211828601413458	0.180097191485127	59/133/816/2697/59345/2791/51764/2981/3485/3488/3553/3569/23764/4846/5142/5333/10266/10268/64407/5999/8490/8787	22
WP3527	Pre-implantation embryo	8/676	35/5963	0.03843052636418	0.212063582776451	0.180296973210748	366/55509/2354/94234/2624/4603/30812/7004	8
WP4136	Fibrin complement receptor 3 signaling pathway	8/676	35/5963	0.03843052636418	0.212063582776451	0.180296973210748	6347/3627/2921/3569/23643/4843/5327/7305	8
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	4/676	12/5963	0.0385158216581162	0.212063582776451	0.180296973210748	2099/2335/8061/7076	4
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	13/676	68/5963	0.0395726223827553	0.215348689245692	0.183089978710912	816/6347/1594/1673/10964/3458/3569/64127/23236/5333/6772/7097/51311	13
WP4538	Regulatory circuits of the STAT3 signaling pathway	14/676	75/5963	0.0401445634779093	0.215950065605305	0.183601270352689	1271/1438/1439/1441/2149/2151/9002/3595/3601/3559/3563/9180/5159/9021	14
WP3670	Interactions between LOXL4 and oxidative stress pathway	5/676	18/5963	0.0450682259109758	0.236987974453221	0.201487751559419	308/1280/2252/2335/3490	5
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	5/676	18/5963	0.0450682259109758	0.236987974453221	0.201487751559419	1014/1004/2335/6615/3371	5
WP75	Toll-like receptor signaling pathway	15/676	84/5963	0.0486011762283752	0.252726116387551	0.21486835806229	6348/6351/941/942/3627/6373/4283/3553/3569/23643/8503/6696/6772/7097/51311	15
WP4723	Omega-3 / omega-6 fatty acid synthesis	4/676	13/5963	0.0507878246403486	0.256370461717719	0.21796678931466	2180/2182/54898/3992	4
WP4724	Omega-9 fatty acid synthesis	4/676	13/5963	0.0507878246403486	0.256370461717719	0.21796678931466	2180/2182/54898/3992	4
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	21/676	128/5963	0.0509454122644186	0.256370461717719	0.21796678931466	116/720/721/1051/1103/1139/2328/2624/2697/3091/3359/3552/3553/3557/3569/3764/4915/6507/6869/7018/7068	21
WP4331	Neovascularisation processes	8/676	37/5963	0.0516040231877417	0.256922157998544	0.21843584283277	284/3091/3791/4854/4855/5155/7042/7043	8
WP4969	RAS and bradykinin pathways in COVID-19	6/676	25/5963	0.056057112308902	0.276155037479644	0.234787683687146	3552/3553/3827/4846/5054/710	6
WP43	Oxidation by cytochrome P450	8/676	38/5963	0.0591599890739329	0.288404946735423	0.245202586293274	1543/1545/56603/1594/1555/1577/1551/9420	8
WP3971	OSX and miRNAs in tooth development	4/676	14/5963	0.0649396097264475	0.313316879917293	0.266382772399318	249/407024/4854/4855	4
WP5053	Development of ureteric collection system	10/676	53/5963	0.0711959284388847	0.33999688274896	0.289066175616525	2296/80144/341640/10468/2737/3237/8516/6092/6469/7042	10
WP5122	Prostaglandin and leukotriene metabolism in senescence 	6/676	27/5963	0.0773100345114505	0.365465617690493	0.310719755931189	247/3488/23236/9536/5743/6916	6
WP4816	TGF-beta receptor signaling in skeletal dysplasias	10/676	54/5963	0.0789531328348382	0.369500661667043	0.314150360121777	25805/2022/2200/10468/3458/3624/10637/5054/6696/6772	10
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	4/676	15/5963	0.0809164061107264	0.371263510390392	0.315649138388592	19/9388/4023/255738	4
WP5174	Ulcerative colitis signaling	4/676	15/5963	0.0809164061107264	0.371263510390392	0.315649138388592	50943/3458/64127/7097	4
WP1591	Heart development	7/676	34/5963	0.0828680554437434	0.376526698521087	0.320123913722381	2255/2296/2626/9464/23493/4776/6469	7
WP4540	Hippo signaling regulation pathways	14/676	84/5963	0.0887255312359107	0.398566561277414	0.338862258575939	1009/1012/1014/1001/1003/1004/2321/3791/26524/4915/5159/23236/7004/7010	14
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	6/676	28/5963	0.0894219849019839	0.398566561277414	0.338862258575939	9509/1277/1278/60681/4015/871	6
WP2371	Parkinson's disease pathway	7/676	35/5963	0.0939774377136341	0.414919253301705	0.35276535705813	2861/120892/100506755/6622/9627/9246/7345	7
WP1423	Ganglio sphingolipid metabolism	3/676	10/5963	0.0948761777387065	0.414972440950604	0.352810577326425	8708/2523/30815	3
WP236	Adipogenesis	18/676	115/5963	0.0961842565810402	0.416798445184507	0.354363050561727	1051/1271/56603/2624/2626/3091/3569/4023/10135/5008/5346/5054/8651/9021/6695/6772/7291/25937	18
WP247	Small ligand GPCRs	4/676	16/5963	0.0986310954440014	0.419630478798115	0.35677085241945	5724/5737/5739/9294	4
WP516	Hypertrophy model	4/676	16/5963	0.0986310954440014	0.419630478798115	0.35677085241945	3458/3552/3554/8013	4
WP2374	Oncostatin M signaling pathway	11/676	64/5963	0.103326969952979	0.435648846288234	0.370389707370563	6347/1051/3091/4312/4322/4314/5008/9180/5054/9021/6772	11
WP560	TGF-beta receptor signaling	9/676	50/5963	0.106545713453086	0.445208874071824	0.378517666214911	25805/2022/10468/3458/3624/10637/5054/6696/6772	9
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	5/676	23/5963	0.110920040302715	0.455355954926936	0.387144739006706	285/2022/2200/10631/5054	5
WP3893	Development and heterogeneity of the ILC family	5/676	23/5963	0.110920040302715	0.455355954926936	0.387144739006706	3458/3605/3553/90865/3569	5
WP2880	Glucocorticoid receptor pathway	11/676	65/5963	0.112372064342024	0.457305444452757	0.388802199737162	6347/6364/3589/89795/5142/5743/5272/1836/5552/7056/84951	11
WP3874	Canonical and non-canonical TGF-B signaling	4/676	17/5963	0.117970125850133	0.467618491258258	0.397570377183134	26585/4015/4016/4017	4
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	4/676	17/5963	0.117970125850133	0.467618491258258	0.397570377183134	249/1594/6098/6696	4
WP691	Tamoxifen metabolism	4/676	17/5963	0.117970125850133	0.467618491258258	0.397570377183134	1543/1545/1577/2328	4
WP3630	NAD metabolism, sirtuins and aging	3/676	11/5963	0.119902177245707	0.467618491258258	0.397570377183134	3091/10135/6098	3
WP5052	Nephrogenesis	3/676	11/5963	0.119902177245707	0.467618491258258	0.397570377183134	8854/4211/84870	3
WP5036	Angiotensin II receptor type 1 pathway	5/676	24/5963	0.127761110904205	0.494150412422874	0.420127881007302	59/1277/1278/3091/3589	5
WP2858	Ectoderm differentiation	18/676	120/5963	0.13003056518362	0.498805774638805	0.424085881271859	91653/6347/1004/54898/2737/57476/9687/3853/9079/4061/22871/5783/4920/6469/6622/6781/7020/7022	18
WP3927	BMP signaling in eyelid development	4/676	18/5963	0.138799240118463	0.528114181914152	0.449003960331871	2255/2296/6422/6469	4
WP2064	Neural crest differentiation	11/676	68/5963	0.142116555864287	0.533414654439188	0.453510434948297	1004/1302/1280/2247/23493/4488/4854/4855/6615/7020/7291	11
WP4900	Purinergic signaling	5/676	25/5963	0.14568711055303	0.533414654439188	0.453510434948297	134/5027/53829/9934/5031	5
WP4565	Neural crest cell migration in cancer	7/676	39/5963	0.146065335212324	0.533414654439188	0.453510434948297	1009/2047/2151/4313/4915/8503/7291	7
WP2881	Estrogen receptor pathway	3/676	12/5963	0.147030962441571	0.533414654439188	0.453510434948297	1543/1545/2099	3
WP3892	Development of pulmonary dendritic cells and macrophage subsets	3/676	12/5963	0.147030962441571	0.533414654439188	0.453510434948297	55509/1437/6688	3
WP4495	IL-10 anti-inflammatory signaling pathway 	3/676	12/5963	0.147030962441571	0.533414654439188	0.453510434948297	3552/3569/6772	3
WP2882	Nuclear receptors meta-pathway	36/676	268/5963	0.156381377318519	0.562972958346668	0.478640976731985	8647/874/6347/6364/1543/1545/1555/1577/1551/2099/3082/3458/3589/3553/55554/23764/89795/3084/5142/5155/9588/5743/5272/1836/154091/6515/29986/160728/11254/23657/8140/5552/27286/7042/7056/84951	36
WP5130	Th17 cell differentiation pathway	10/676	62/5963	0.158829454055032	0.567421255708053	0.482422929954215	50943/3091/3458/3605/3553/3559/3569/861/9021/6772	10
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	5/676	26/5963	0.164616090999862	0.579250605924328	0.492480272243356	9536/5737/5739/5743/6916	5
WP4875	Disruption of postsynaptic signaling by CNV	5/676	26/5963	0.164616090999862	0.579250605924328	0.492480272243356	816/2906/9456/22871/57555	5
WP3646	Hepatitis C and hepatocellular carcinoma	8/676	48/5963	0.170731679853454	0.596286762473257	0.506964453924631	1284/3577/3091/3569/4312/4843/5743/7345	8
WP1434	Osteopontin signaling	3/676	13/5963	0.175903903781938	0.596543673695266	0.50718288046966	3690/5328/6696	3
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	3/676	13/5963	0.175903903781938	0.596543673695266	0.50718288046966	249/6422/7015	3
WP3958	GPR40 pathway	3/676	13/5963	0.175903903781938	0.596543673695266	0.50718288046966	23236/5333/113026	3
WP554	ACE inhibitor pathway	3/676	13/5963	0.175903903781938	0.596543673695266	0.50718288046966	1511/3827/4846	3
WP4298	Acute viral myocarditis	12/676	79/5963	0.179159882843896	0.603214569575132	0.512854492351327	199/834/1232/1604/941/3458/3569/3908/64127/6444/8651/6772	12
WP167	Eicosanoid synthesis	4/676	20/5963	0.184318915043098	0.603681959668616	0.513251868544167	247/9536/5743/6916	4
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	4/676	20/5963	0.184318915043098	0.603681959668616	0.513251868544167	2626/3569/3791/6696	4
WP5044	Kynurenine pathway and links to cell senescence	4/676	20/5963	0.184318915043098	0.603681959668616	0.513251868544167	3620/3458/8942/6999	4
WP5121	Sphingolipid metabolism in senescence	5/676	27/5963	0.18445837656541	0.603681959668616	0.513251868544167	23236/9294/55512/8877/7015	5
WP364	IL6 signaling pathway	7/676	42/5963	0.192379145021199	0.625232221318897	0.53157395334805	3055/3569/639/9021/6772/7076/7432	7
WP2324	AGE/RAGE pathway	10/676	65/5963	0.196364519459737	0.633783414532116	0.538844198590058	249/3091/4322/4323/4313/4316/4481/4843/4846/6772	10
WP4561	Cell migration and invasion through p75NTR	5/676	28/5963	0.205118461709634	0.647557758098428	0.55055517895008	1009/1944/4313/4915/7291	5
WP1602	Nicotine effect on dopaminergic neurons	3/676	14/5963	0.206166893069799	0.647557758098428	0.55055517895008	1138/3777/6571	3
WP3935	Leptin-insulin signaling overlap	3/676	14/5963	0.206166893069799	0.647557758098428	0.55055517895008	8503/8651/9021	3
WP4582	Cancer immunotherapy by CTLA4 blockade	3/676	14/5963	0.206166893069799	0.647557758098428	0.55055517895008	941/942/8503	3
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	4/676	21/5963	0.208683361014806	0.64774432886841	0.550713801871927	941/942/3101/6515	4
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	7/676	43/5963	0.208994430895577	0.64774432886841	0.550713801871927	816/2906/116443/9456/4915/8503/85358	7
WP4564	Neural crest cell migration during development	6/676	36/5963	0.217888666716455	0.6708677369954	0.570373379631717	1009/2047/2151/4313/8503/7291	6
WP4018	Clear cell renal cell carcinoma pathways	12/676	83/5963	0.226668618590875	0.693339303925029	0.58947876042209	1012/2321/3091/3101/3759/3791/5155/5159/29968/10993/7042/7043	12
WP3591	Sleep regulation	4/676	22/5963	0.233893851643559	0.709810646709701	0.603482736068976	134/3569/22871/4887	4
WP2118	Arrhythmogenic right ventricular cardiomyopathy	9/676	60/5963	0.235086859487187	0.709810646709701	0.603482736068976	87/2697/22801/3673/3678/8516/3690/3908/6444	9
WP4842	Mammalian disorder of sexual development	3/676	15/5963	0.237479514809566	0.712438544428699	0.605716981093226	10468/2626/30812	3
WP536	Calcium regulation in cardiac cells	17/676	125/5963	0.247026089703031	0.736358025356806	0.626053381882305	147/777/816/2697/2701/2702/2707/127534/10052/59345/2791/51764/5350/64407/5999/8490/8787	17
WP4197	Immune response to tuberculosis	4/676	23/5963	0.259783075083737	0.755145833162665	0.642026821717245	8519/8651/6772/6890	4
WP4483	Relationship between inflammation, COX-2 and EGFR	4/676	23/5963	0.259783075083737	0.755145833162665	0.642026821717245	2099/4312/51365/5743	4
WP4585	Cancer immunotherapy by PD-1 blockade	4/676	23/5963	0.259783075083737	0.755145833162665	0.642026821717245	29126/3458/4776/80380	4
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	4/676	23/5963	0.259783075083737	0.755145833162665	0.642026821717245	3553/3569/10135/23057	4
WP3942	PPAR signaling pathway	8/676	54/5963	0.264467315431934	0.763760735852734	0.649351232911231	2180/2182/126129/4023/4312/4973/5346/28965	8
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	11/676	78/5963	0.266010683641016	0.763760735852734	0.649351232911231	8061/11211/283120/5328/4920/6422/6423/64321/7020/7472/7474	11
WP4241	Type 2 papillary renal cell carcinoma	5/676	31/5963	0.270999774822725	0.77334082083558	0.657496244435109	1513/3091/5155/7042/7043	5
WP4542	Leukocyte-intrinsic Hippo pathway functions	5/676	32/5963	0.293919392162621	0.833662275952162	0.708781692105077	50943/26524/4023/639/7004	5
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	10/676	72/5963	0.296218819767962	0.835122937659074	0.71002355023646	8061/11211/5328/4920/6422/6423/64321/83595/7472/7474	10
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	3/676	17/5963	0.30199674314507	0.84127664161841	0.715255444290956	10631/3371/7472	3
WP4784	Proteoglycan biosynthesis	3/676	17/5963	0.30199674314507	0.84127664161841	0.715255444290956	9469/55790/1836	3
WP4950	16p11.2 distal deletion syndrome	4/676	25/5963	0.31294944075138	0.85040663381374	0.723017785833544	1380/8519/3791/5350	4
WP581	EPO receptor signaling	4/676	25/5963	0.31294944075138	0.85040663381374	0.723017785833544	5163/10076/8651/6772	4
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	2/676	10/5963	0.315914419675169	0.85040663381374	0.723017785833544	1116/9021	2
WP4846	SARS-CoV-2 and COVID-19 pathway	2/676	10/5963	0.315914419675169	0.85040663381374	0.723017785833544	1514/8829	2
WP4655	Cytosolic DNA-sensing pathway	8/676	57/5963	0.316135576472973	0.85040663381374	0.723017785833544	834/6351/9560/3627/3553/90865/3569/81030	8
WP428	Wnt signaling	13/676	98/5963	0.316176825392288	0.85040663381374	0.723017785833544	816/8061/11211/4776/5328/23236/166336/4920/6422/6423/64321/7472/7474	13
WP4217	Ebola virus infection in host	16/676	124/5963	0.329230030695153	0.8749148719284	0.74385474941281	87/432/684/11314/10332/93978/1514/26762/84868/3673/3678/3690/8503/9021/6772/7020	16
WP3877	MYD88 distinct input-output pathway	3/676	18/5963	0.334636243750392	0.8749148719284	0.74385474941281	3552/7097/51311	3
WP4533	Transcription co-factors SKI and SKIL protein partners	3/676	18/5963	0.334636243750392	0.8749148719284	0.74385474941281	26524/23314/7004	3
WP4760	PKC-gamma calcium signaling pathway in ataxia	3/676	18/5963	0.334636243750392	0.8749148719284	0.74385474941281	2769/5163/23236	3
WP5149	Lipid metabolism in senescent cells	3/676	18/5963	0.334636243750392	0.8749148719284	0.74385474941281	50487/7941/5743	3
WP299	Nuclear receptors in lipid metabolism and toxicity	4/676	26/5963	0.339919140706201	0.883789765836122	0.751400205771602	19/8647/1594/1555	4
WP4963	p53 transcriptional gene network	8/676	59/5963	0.351616489720429	0.909152028669396	0.772963263241187	6347/126129/6376/55332/3383/4688/5054/23657	8
WP4947	Nitric oxide metabolism in cystic fibrosis	2/676	11/5963	0.359472695770605	0.909254371850571	0.773050275662429	4843/4846	2
WP5191	ResolvinE1 and ResolvinD1 signaling pathways promoting inflammation resolution	2/676	11/5963	0.359472695770605	0.909254371850571	0.773050275662429	2358/5163	2
WP2586	Aryl hydrocarbon receptor pathway	6/676	43/5963	0.36033026161092	0.909254371850571	0.773050275662429	1543/1545/2099/4023/135112/5743	6
WP4658	Small cell lung cancer	12/676	93/5963	0.362291931735269	0.909254371850571	0.773050275662429	1282/1284/2335/3673/284217/3908/3910/3915/10319/4843/8503/5743	12
WP5102	Familial partial lipodystrophy (FPLD)	4/676	27/5963	0.366955795339382	0.909254371850571	0.773050275662429	2624/4023/5346/5396	4
WP3599	Transcription factor regulation in adipogenesis	3/676	19/5963	0.367198880939654	0.909254371850571	0.773050275662429	1051/3569/7291	3
WP4961	STING pathway in Kawasaki-like disease and COVID-19	3/676	19/5963	0.367198880939654	0.909254371850571	0.773050275662429	2212/3553/114548	3
WP5181	Roles of ceramides in the development of insulin resistance	3/676	19/5963	0.367198880939654	0.909254371850571	0.773050275662429	2180/3651/55512	3
WP3945	TYROBP causal network in microglia	8/676	61/5963	0.387542873093132	0.94237038207626	0.801205588000059	3142/10261/3687/10008/4688/5341/6696/7305	8
WP2873	Aryl hydrocarbon receptor pathway	5/676	36/5963	0.387747044372611	0.94237038207626	0.801205588000059	1543/1545/3458/3553/8140	5
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	5/676	36/5963	0.387747044372611	0.94237038207626	0.801205588000059	684/8519/10581/10410/6196	5
WP2870	Extracellular vesicle-mediated signaling in recipient cells	4/676	28/5963	0.393928684277673	0.94237038207626	0.801205588000059	3082/7042/7043/7474	4
WP4481	Resistin as a regulator of inflammation	4/676	28/5963	0.393928684277673	0.94237038207626	0.801205588000059	3569/23236/5333/113026	4
WP3640	Imatinib and chronic myeloid leukemia	3/676	20/5963	0.39947181609787	0.94237038207626	0.801205588000059	2321/5159/11040	3
WP3645	NAD+ biosynthetic pathways	3/676	20/5963	0.39947181609787	0.94237038207626	0.801205588000059	3620/10135/6999	3
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	2/676	12/5963	0.401961042436411	0.94237038207626	0.801205588000059	1634/6422	2
WP4211	Transcriptional cascade regulating adipogenesis	2/676	12/5963	0.401961042436411	0.94237038207626	0.801205588000059	1051/2624	2
WP5110	Familial hyperlipidemia type 3	2/676	12/5963	0.401961042436411	0.94237038207626	0.801205588000059	4023/7436	2
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	6/676	45/5963	0.402722385502675	0.94237038207626	0.801205588000059	19/2180/2182/9023/54898/3992	6
WP3888	VEGFA-VEGFR2 signaling pathway	48/676	409/5963	0.420551136041766	0.96993065682412	0.824637400538726	9510/56999/301/81575/22899/813/6347/1003/79094/2022/2078/24147/2321/2335/6624/2523/2624/2697/3142/5654/3383/3490/3690/3791/9079/4319/4323/4313/79812/4688/91624/4846/4855/8013/8828/5228/5328/5329/9588/5743/57381/27289/6401/6648/6772/7004/8794/81567	48
WP2876	Pregnane X receptor pathway	4/676	29/5963	0.420717784904479	0.96993065682412	0.824637400538726	1555/1577/1551/27286	4
WP4698	Vitamin D-sensitive calcium signaling in depression	4/676	29/5963	0.420717784904479	0.96993065682412	0.824637400538726	793/1594/2906/3786	4
WP383	Striated muscle contraction pathway	3/676	21/5963	0.431269891945047	0.989383869756285	0.84117656942842	59/4604/7134	3
WP4787	Osteoblast differentiation and related diseases	12/676	98/5963	0.434507966478321	0.991925194729494	0.843337210093902	2255/2247/2252/11211/2737/23493/4854/4855/8503/6772/7472/7474	12
WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	2/676	13/5963	0.443062340373588	0.991925194729494	0.843337210093902	4312/5743	2
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	2/676	13/5963	0.443062340373588	0.991925194729494	0.843337210093902	3690/7134	2
WP4942	15q13.3 copy number variation syndrome	2/676	13/5963	0.443062340373588	0.991925194729494	0.843337210093902	1139/871	2
WP5176	Disorders of bile acid synthesis and biliary transport	2/676	13/5963	0.443062340373588	0.991925194729494	0.843337210093902	8647/9420	2
WP143	Fatty acid beta-oxidation	4/676	30/5963	0.447214136940007	0.991925194729494	0.843337210093902	2180/2182/8513/4023	4
WP2839	Hair follicle development: organogenesis - part 2 of 3	4/676	30/5963	0.447214136940007	0.991925194729494	0.843337210093902	3624/6469/6615/7474	4
WP4806	EGFR tyrosine kinase inhibitor resistance	10/676	82/5963	0.453955801794909	0.999999929473691	0.850202369188158	2247/3082/3569/3791/22808/3084/5155/5159/8503/399694	10
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	8/676	65/5963	0.459483989348006	0.999999929473691	0.850202369188158	816/941/9076/1514/3690/4868/5329/7225	8
WP3303	RAC1/PAK1/p38/MMP2 pathway	8/676	65/5963	0.459483989348006	0.999999929473691	0.850202369188158	284/285/2335/4313/4843/7010/7075/79931	8
WP4537	Hippo-Yap signaling pathway	3/676	22/5963	0.462434529887387	0.999999929473691	0.850202369188158	3627/26524/7004	3
WP4595	Urea cycle and associated pathways	3/676	22/5963	0.462434529887387	0.999999929473691	0.850202369188158	4843/4846/5831	3
WP4222	Phosphodiesterases in neuronal function	5/676	40/5963	0.480790119116421	0.999999929473691	0.850202369188158	1139/2906/2977/10846/5142	5
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	2/676	14/5963	0.48254491492422	0.999999929473691	0.850202369188158	3589/3569	2
WP4584	Biomarkers for pyrimidine metabolism disorders	2/676	14/5963	0.48254491492422	0.999999929473691	0.850202369188158	1152/1890	2
WP47	Hedgehog signaling pathway	2/676	14/5963	0.48254491492422	0.999999929473691	0.850202369188158	2737/6469	2
WP5061	Fatty acid transporters	2/676	14/5963	0.48254491492422	0.999999929473691	0.850202369188158	2180/2182	2
WP58	Monoamine GPCRs	2/676	14/5963	0.48254491492422	0.999999929473691	0.850202369188158	147/3274	2
WP697	Estrogen metabolism	2/676	14/5963	0.48254491492422	0.999999929473691	0.850202369188158	1543/1545	2
WP3845	Canonical and non-canonical Notch signaling	3/676	23/5963	0.492832248107935	0.999999929473691	0.850202369188158	4237/4854/4855	3
WP4545	Oxysterols derived from cholesterol	4/676	32/5963	0.498948622107957	0.999999929473691	0.850202369188158	9023/9420/2099/3605	4
WP2332	Interleukin-11 signaling pathway	5/676	41/5963	0.503366902536625	0.999999929473691	0.850202369188158	3383/3589/3673/9021/6772	5
WP2855	Dopaminergic neurogenesis	2/676	15/5963	0.520247284172628	0.999999929473691	0.850202369188158	6469/6571	2
WP3	Transcriptional activation by NRF2 in response to phytochemicals	2/676	15/5963	0.520247284172628	0.999999929473691	0.850202369188158	1051/23657	2
WP5109	Familial hyperlipidemia type 2	2/676	15/5963	0.520247284172628	0.999999929473691	0.850202369188158	4023/255738	2
WP26	S1P receptor signal transduction	3/676	24/5963	0.522352930991976	0.999999929473691	0.850202369188158	23236/9294/8877	3
WP3529	Zinc homeostasis	4/676	33/5963	0.524024319531372	0.999999929473691	0.850202369188158	4494/4499/55532/29986	4
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	6/676	52/5963	0.546755504787582	0.999999929473691	0.850202369188158	308/79092/2149/3084/8767/9021	6
WP3644	NAD+ metabolism	2/676	16/5963	0.556065259377277	0.999999929473691	0.850202369188158	10135/23057	2
WP368	Mitochondrial long chain fatty acid beta-oxidation	2/676	16/5963	0.556065259377277	0.999999929473691	0.850202369188158	2180/2182	2
WP4558	Overview of interferons-mediated signaling pathway	2/676	16/5963	0.556065259377277	0.999999929473691	0.850202369188158	3458/6772	2
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	2/676	16/5963	0.556065259377277	0.999999929473691	0.850202369188158	3569/64386	2
WP4970	Galanin receptor pathway	2/676	16/5963	0.556065259377277	0.999999929473691	0.850202369188158	3569/7020	2
WP2884	NRF2 pathway	13/676	116/5963	0.562105744951097	0.999999929473691	0.850202369188158	874/3082/23764/3084/5155/9588/154091/6515/29986/160728/11254/23657/7042	13
WP702	Metapathway biotransformation Phase I and II	14/676	125/5963	0.562226244370416	0.999999929473691	0.850202369188158	1645/9469/1543/1545/56603/1594/1555/1577/1551/9420/2328/64090/90161/4837	14
WP4746	Thyroid hormones production and peripheral downstream signaling effects	9/676	80/5963	0.562818051749836	0.999999929473691	0.850202369188158	50506/405753/3690/23236/5346/6469/6567/7068/7253	9
WP2359	Parkin-ubiquitin proteasomal system pathway	7/676	62/5963	0.564562374103564	0.999999929473691	0.850202369188158	834/2861/3310/6622/9627/347733/9246	7
WP4657	22q11.2 copy number variation syndrome	10/676	90/5963	0.577210198807864	0.999999929473691	0.850202369188158	59/150209/8854/9076/56603/2255/2296/9464/6469/7450	10
WP241	One-carbon metabolism	3/676	26/5963	0.578428232173058	0.999999929473691	0.850202369188158	10840/2346/219595	3
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	3/676	26/5963	0.578428232173058	0.999999929473691	0.850202369188158	5744/6615/6772	3
WP195	IL-1 signaling pathway	6/676	54/5963	0.58513170196036	0.999999929473691	0.850202369188158	6347/3552/3553/3554/3556/11213	6
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	5/676	45/5963	0.589268903199296	0.999999929473691	0.850202369188158	6356/3055/3559/3569/6772	5
WP4560	MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement	2/676	17/5963	0.589941061541571	0.999999929473691	0.850202369188158	87/3690	2
WP5074	Kallmann syndrome	2/676	17/5963	0.589941061541571	0.999999929473691	0.850202369188158	23129/60675	2
WP4673	Male infertility	11/676	100/5963	0.590258998167889	0.999999929473691	0.850202369188158	1543/56603/2099/2346/219595/4313/4843/4846/29968/8787/6648	11
WP4249	Hedgehog signaling pathway	4/676	37/5963	0.617639501157848	0.999999929473691	0.850202369188158	91653/2619/2737/6469	4
WP497	Urea cycle and metabolism of amino groups	2/676	18/5963	0.621854163765469	0.999999929473691	0.850202369188158	1152/5831	2
WP5033	Genes associated with the development of rheumatoid arthritis	2/676	18/5963	0.621854163765469	0.999999929473691	0.850202369188158	3559/23569	2
WP286	IL-3 signaling pathway	5/676	47/5963	0.629025016350365	0.999999929473691	0.850202369188158	1232/942/1439/3055/3563	5
WP2895	Differentiation of white and brown adipocyte	2/676	19/5963	0.6518136088038	0.999999929473691	0.850202369188158	1051/253738	2
WP325	Triacylglyceride synthesis	2/676	19/5963	0.6518136088038	0.999999929473691	0.850202369188158	8513/4023	2
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	2/676	19/5963	0.6518136088038	0.999999929473691	0.850202369188158	8708/8877	2
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	2/676	19/5963	0.6518136088038	0.999999929473691	0.850202369188158	3091/5163	2
WP5194	Synthesis of ceramides and 1-deoxyceramides	2/676	19/5963	0.6518136088038	0.999999929473691	0.850202369188158	53947/8877	2
WP3676	BDNF-TrkB signaling	3/676	29/5963	0.654342380712535	0.999999929473691	0.850202369188158	9456/4915/7225	3
WP3925	Amino acid metabolism	8/676	77/5963	0.657823436516059	0.999999929473691	0.850202369188158	127/586/3034/3067/5831/10993/6898/6999	8
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	3/676	30/5963	0.677356630020594	0.999999929473691	0.850202369188158	4846/5163/8503	3
WP3580	Methionine de novo and salvage pathway	2/676	20/5963	0.679851585771126	0.999999929473691	0.850202369188158	259307/6898	2
WP4224	Purine metabolism and related disorders	2/676	20/5963	0.679851585771126	0.999999929473691	0.850202369188158	270/316	2
WP2007	Iron metabolism in placenta	1/676	10/5963	0.700066149447212	0.999999929473691	0.850202369188158	7018	1
WP3656	Interleukin-1 induced activation of NF-kB	1/676	10/5963	0.700066149447212	0.999999929473691	0.850202369188158	3552	1
WP4259	Disorders of folate metabolism and transport	1/676	10/5963	0.700066149447212	0.999999929473691	0.850202369188158	10840	1
WP4389	Bile acids synthesis and enterohepatic circulation 	1/676	10/5963	0.700066149447212	0.999999929473691	0.850202369188158	8647	1
WP5050	TCA cycle in senescence	1/676	10/5963	0.700066149447212	0.999999929473691	0.850202369188158	5163	1
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	1/676	10/5963	0.700066149447212	0.999999929473691	0.850202369188158	629	1
WP5187	mRNA vaccine activation of dendritic cell and induction of IFN-1	1/676	10/5963	0.700066149447212	0.999999929473691	0.850202369188158	51311	1
WP262	Ebstein-Barr virus LMP1 signaling	2/676	21/5963	0.706018079858081	0.999999929473691	0.850202369188158	6364/9260	2
WP4905	1q21.1 copy number variation syndrome	2/676	21/5963	0.706018079858081	0.999999929473691	0.850202369188158	2697/2702	2
WP357	Fatty acid biosynthesis	2/676	22/5963	0.73037643485515	0.999999929473691	0.850202369188158	2180/2182	2
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	2/676	22/5963	0.73037643485515	0.999999929473691	0.850202369188158	597/5744	2
WP229	Irinotecan pathway	1/676	11/5963	0.734125494814873	0.999999929473691	0.850202369188158	1577	1
WP3679	Cell-type dependent selectivity of CCK2R signaling	1/676	11/5963	0.734125494814873	0.999999929473691	0.850202369188158	23236	1
WP3871	Valproic acid pathway	1/676	11/5963	0.734125494814873	0.999999929473691	0.850202369188158	1555	1
WP3930	EDA signaling in hair follicle development	1/676	11/5963	0.734125494814873	0.999999929473691	0.850202369188158	6469	1
WP4271	Vitamin B12 disorders	1/676	11/5963	0.734125494814873	0.999999929473691	0.850202369188158	6947	1
WP4583	Biomarkers for urea cycle disorders	1/676	11/5963	0.734125494814873	0.999999929473691	0.850202369188158	2155	1
WP4788	Autosomal recessive osteopetrosis pathways	1/676	11/5963	0.734125494814873	0.999999929473691	0.850202369188158	29887	1
WP4919	Neuroinflammation	1/676	11/5963	0.734125494814873	0.999999929473691	0.850202369188158	4843	1
WP244	Alpha 6 beta 4 signaling pathway	3/676	33/5963	0.739526279052251	0.999999929473691	0.850202369188158	284217/3908/3915	3
WP4756	Renin-angiotensin-aldosterone system (RAAS)	3/676	33/5963	0.739526279052251	0.999999929473691	0.850202369188158	816/9586/1511	3
WP2267	Synaptic vesicle pathway	4/676	44/5963	0.751109111260501	0.999999929473691	0.850202369188158	6571/6507/6812/6853	4
WP1772	Apoptosis modulation and signaling	8/676	84/5963	0.751172549487761	0.999999929473691	0.850202369188158	597/638/834/8739/3554/4671/5783/8794	8
WP34	Ovarian infertility	2/676	23/5963	0.752999690735838	0.999999929473691	0.850202369188158	1051/2701	2
WP4357	NRF2-ARE regulation	2/676	23/5963	0.752999690735838	0.999999929473691	0.850202369188158	1051/23657	2
WP2023	Cell differentiation - expanded index	1/676	12/5963	0.764322263212915	0.999999929473691	0.850202369188158	10637	1
WP4792	Purine metabolism	1/676	12/5963	0.764322263212915	0.999999929473691	0.850202369188158	270	1
WP5112	Familial hyperlipidemia type 5	1/676	12/5963	0.764322263212915	0.999999929473691	0.850202369188158	4023	1
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	2/676	24/5963	0.77396757798528	0.999999929473691	0.850202369188158	247/2358	2
WP4925	Unfolded protein response	2/676	24/5963	0.77396757798528	0.999999929473691	0.850202369188158	3553/7494	2
WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	2/676	24/5963	0.77396757798528	0.999999929473691	0.850202369188158	2769/23236	2
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	2/676	24/5963	0.77396757798528	0.999999929473691	0.850202369188158	3569/114548	2
WP4566	Translation inhibitors in chronically activated PDGFRA cells	4/676	46/5963	0.781894526912769	0.999999929473691	0.850202369188158	5163/8503/11040/6196	4
WP61	Notch signaling pathway	5/676	57/5963	0.790018140052551	0.999999929473691	0.850202369188158	1840/23493/3091/4854/4855	5
WP2289	Drug induction of bile acid pathway	1/676	13/5963	0.791093923449526	0.999999929473691	0.850202369188158	8647	1
WP3853	ERK pathway in Huntington's disease	1/676	13/5963	0.791093923449526	0.999999929473691	0.850202369188158	4915	1
WP5108	Familial  hyperlipidemia type 1	1/676	13/5963	0.791093923449526	0.999999929473691	0.850202369188158	4023	1
WP5192	Modulation of the PI3K-Akt-mTOR signaling by bioactive sphingolipids	1/676	13/5963	0.791093923449526	0.999999929473691	0.850202369188158	3091	1
WP1528	Physiological and pathological hypertrophy of the heart	2/676	25/5963	0.793364067167615	0.999999929473691	0.850202369188158	2626/4776	2
WP205	IL-7 signaling pathway	2/676	25/5963	0.793364067167615	0.999999929473691	0.850202369188158	3559/6772	2
WP3613	Photodynamic therapy-induced unfolded protein response	2/676	25/5963	0.793364067167615	0.999999929473691	0.850202369188158	121506/7494	2
WP430	Statin inhibition of cholesterol production	2/676	25/5963	0.793364067167615	0.999999929473691	0.850202369188158	19/4023	2
WP1403	AMP-activated protein kinase (AMPK) signaling	5/676	58/5963	0.80261452510226	0.999999929473691	0.850202369188158	147/126129/5209/8503/23236	5
WP4262	Breast cancer pathway	12/676	129/5963	0.807781553385519	0.999999929473691	0.850202369188158	2099/2255/2247/2252/11211/23493/4854/4855/8503/399694/7472/7474	12
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	2/676	26/5963	0.811275386750495	0.999999929473691	0.850202369188158	1051/2099	2
WP3851	TLR4 signaling and tolerance	2/676	26/5963	0.811275386750495	0.999999929473691	0.850202369188158	3569/11213	2
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	2/676	26/5963	0.811275386750495	0.999999929473691	0.850202369188158	4915/8503	2
WP2879	Farnesoid X receptor pathway	1/676	14/5963	0.814828462566857	0.999999929473691	0.850202369188158	8647	1
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	1/676	14/5963	0.814828462566857	0.999999929473691	0.850202369188158	283120	1
WP4758	Nephrotic syndrome	3/676	38/5963	0.821568465185877	0.999999929473691	0.850202369188158	8542/4868/7225	3
WP3611	Photodynamic therapy-induced AP-1 survival signaling	4/676	49/5963	0.822310018868894	0.999999929473691	0.850202369188158	2252/3458/3569/4313	4
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	4/676	49/5963	0.822310018868894	0.999999929473691	0.850202369188158	1051/1513/6696/7042	4
WP5098	T-cell activation SARS-CoV-2	7/676	81/5963	0.827370232894	0.999999929473691	0.850202369188158	941/942/3458/3595/3605/8809/3937	7
WP2112	IL-17 signaling pathway	2/676	27/5963	0.827788434748353	0.999999929473691	0.850202369188158	1051/3605	2
WP2643	Nanoparticle-mediated activation of receptor signaling	2/676	27/5963	0.827788434748353	0.999999929473691	0.850202369188158	1277/2335	2
WP2875	Constitutive androstane receptor pathway	2/676	27/5963	0.827788434748353	0.999999929473691	0.850202369188158	1555/1577	2
WP2526	PDGF pathway	3/676	39/5963	0.835042298169581	0.999999929473691	0.850202369188158	5155/5159/6772	3
WP2828	Bladder cancer	3/676	39/5963	0.835042298169581	0.999999929473691	0.850202369188158	4312/4313/1890	3
WP4962	Airway smooth muscle cell contraction	1/676	15/5963	0.835869975309302	0.999999929473691	0.850202369188158	23236	1
WP5101	Congenital generalized lipodystrophy (CGL)	1/676	15/5963	0.835869975309302	0.999999929473691	0.850202369188158	3091	1
WP4313	Ferroptosis	5/676	61/5963	0.836836705306845	0.999999929473691	0.850202369188158	2180/2182/1645/23657/7018	5
WP4150	Wnt signaling in kidney disease	2/676	28/5963	0.84298952056921	0.999999929473691	0.850202369188158	7472/7474	2
WP4838	Regucalcin in proximal tubule epithelial kidney cells	2/676	28/5963	0.84298952056921	0.999999929473691	0.850202369188158	59/9104	2
WP3940	One-carbon metabolism and related pathways	3/676	40/5963	0.84763100185272	0.999999929473691	0.850202369188158	586/23743/6648	3
WP4312	Rett syndrome causing genes	3/676	40/5963	0.84763100185272	0.999999929473691	0.850202369188158	23314/85358/6812	3
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	1/676	16/5963	0.854523623038103	0.999999929473691	0.850202369188158	19	1
WP22	IL-9 signaling pathway	1/676	16/5963	0.854523623038103	0.999999929473691	0.850202369188158	6772	1
WP4225	Pyrimidine metabolism and related diseases	1/676	16/5963	0.854523623038103	0.999999929473691	0.850202369188158	1890	1
WP395	IL-4 signaling pathway	4/676	52/5963	0.85633719703407	0.999999929473691	0.850202369188158	1051/8651/9021/6772	4
WP3972	PDGFR-beta pathway	2/676	29/5963	0.856963382780815	0.999999929473691	0.850202369188158	5159/6772	2
WP408	Oxidative stress response	2/676	29/5963	0.856963382780815	0.999999929473691	0.850202369188158	1543/6648	2
WP268	Notch signaling	3/676	41/5963	0.859376595628363	0.999999929473691	0.850202369188158	1840/4854/4855	3
WP4290	Metabolic reprogramming in colon cancer	3/676	41/5963	0.859376595628363	0.999999929473691	0.850202369188158	3101/29968/5831	3
WP49	IL-2 signaling pathway	3/676	41/5963	0.859376595628363	0.999999929473691	0.850202369188158	3559/9021/6772	3
WP2034	Leptin signaling pathway	6/676	75/5963	0.867678326218791	0.999999929473691	0.850202369188158	2099/3553/3557/4846/9021/6772	6
WP3858	Toll-like receptor signaling related to MyD88	2/676	30/5963	0.869792436549402	0.999999929473691	0.850202369188158	7097/51311	2
WP4149	White fat cell differentiation	2/676	30/5963	0.869792436549402	0.999999929473691	0.850202369188158	1051/2624	2
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	2/676	30/5963	0.869792436549402	0.999999929473691	0.850202369188158	6772/7097	2
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	3/676	42/5963	0.870321258687718	0.999999929473691	0.850202369188158	59/3690/7004	3
WP4917	Proximal tubule transport	3/676	42/5963	0.870321258687718	0.999999929473691	0.850202369188158	760/762/160728	3
WP69	T-cell receptor signaling pathway	7/676	86/5963	0.870429747666857	0.999999929473691	0.850202369188158	3601/3605/3552/3553/3569/3937/8767	7
WP4912	SARS coronavirus and innate immunity	1/676	17/5963	0.871060033131637	0.999999929473691	0.850202369188158	6772	1
WP5111	Familial hyperlipidemia type 4	1/676	17/5963	0.871060033131637	0.999999929473691	0.850202369188158	4023	1
WP5200	Dravet syndrome	1/676	17/5963	0.871060033131637	0.999999929473691	0.850202369188158	6324	1
WP2853	Endoderm differentiation	10/676	118/5963	0.875261208650573	0.999999929473691	0.850202369188158	1846/2626/3227/3915/5744/6422/154091/64321/83595/6772	10
WP2018	RANKL/RANK signaling pathway	4/676	54/5963	0.875807932193155	0.999999929473691	0.850202369188158	1513/3383/6688/6772	4
WP399	Wnt signaling pathway and pluripotency	7/676	87/5963	0.877886401835352	0.999999929473691	0.850202369188158	8061/11211/120892/4316/5328/7472/7474	7
WP1971	Integrated cancer pathway	3/676	43/5963	0.88050694882828	0.999999929473691	0.850202369188158	994/4312/6772	3
WP4844	Influence of laminopathies on Wnt signaling	2/676	31/5963	0.881556211420928	0.999999929473691	0.850202369188158	1051/6696	2
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	2/676	31/5963	0.881556211420928	0.999999929473691	0.850202369188158	5163/23236	2
WP366	TGF-beta signaling pathway	11/676	130/5963	0.88560765300259	0.999999929473691	0.850202369188158	1278/2335/2354/50943/3673/3690/4312/4321/5163/7015/3371	11
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	1/676	18/5963	0.885719201917882	0.999999929473691	0.850202369188158	22808	1
WP4223	Ras signaling	14/676	161/5963	0.887700655335843	0.999999929473691	0.850202369188158	2321/59345/2791/51764/3791/22808/4915/5159/8503/51365/50487/115727/399694/7010	14
WP4971	Phosphoinositides metabolism	3/676	44/5963	0.889975083284459	0.999999929473691	0.850202369188158	23236/5333/113026	3
WP3298	Melatonin metabolism and effects	2/676	32/5963	0.892330946060784	0.999999929473691	0.850202369188158	1543/1545	2
WP1584	Type II diabetes mellitus	1/676	19/5963	0.898713957090886	0.999999929473691	0.850202369188158	3651	1
WP5103	Progeria-associated lipodystrophy	1/676	19/5963	0.898713957090886	0.999999929473691	0.850202369188158	2200	1
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	1/676	19/5963	0.898713957090886	0.999999929473691	0.850202369188158	2626	1
WP3981	miRNA regulation of prostate cancer signaling pathways	2/676	33/5963	0.902189311674238	0.999999929473691	0.850202369188158	354/5159	2
WP1544	MicroRNAs in cardiomyocyte hypertrophy	6/676	80/5963	0.903916947541739	0.999999929473691	0.850202369188158	2247/2626/4776/3084/8503/7474	6
WP3931	Embryonic stem cell pluripotency pathways	7/676	91/5963	0.904233697814693	0.999999929473691	0.850202369188158	2255/2247/2252/5155/5159/7472/7474	7
WP5180	DYRK1A	4/676	58/5963	0.907991228208252	0.999999929473691	0.850202369188158	273/2247/3092/26524	4
WP2878	PPAR-alpha pathway	1/676	20/5963	0.91023302926561	0.999999929473691	0.850202369188158	55554	1
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	1/676	20/5963	0.91023302926561	0.999999929473691	0.850202369188158	3002	1
WP4725	Sphingolipid metabolism overview	1/676	20/5963	0.91023302926561	0.999999929473691	0.850202369188158	8877	1
WP710	DNA damage response (only ATM dependent)	8/676	103/5963	0.910850865902228	0.999999929473691	0.850202369188158	638/8061/5163/8503/5328/6648/7472/7474	8
WP170	Nuclear receptors	2/676	34/5963	0.911200240209874	0.999999929473691	0.850202369188158	2099/7068	2
WP400	p38 MAPK signaling pathway	2/676	34/5963	0.911200240209874	0.999999929473691	0.850202369188158	6772/7042	2
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	4/676	59/5963	0.914782838244168	0.999999929473691	0.850202369188158	1437/3458/3937/5163	4
WP4288	MTHFR deficiency	1/676	21/5963	0.920443776735987	0.999999929473691	0.850202369188158	2906	1
WP4726	Sphingolipid metabolism: integrated pathway	1/676	21/5963	0.920443776735987	0.999999929473691	0.850202369188158	8877	1
WP185	Integrin-mediated cell adhesion	7/676	94/5963	0.920668201869148	0.999999929473691	0.850202369188158	11131/22801/3673/3678/8516/3687/3690	7
WP51	Regulation of actin cytoskeleton	10/676	127/5963	0.923124917077416	0.999999929473691	0.850202369188158	87/2149/2255/2247/2252/2335/22808/5155/5159/8503	10
WP382	MAPK signaling pathway	18/676	210/5963	0.92334473884359	0.999999929473691	0.850202369188158	777/994/1846/2255/2247/2252/3310/3552/3553/3554/120892/22808/4915/5155/5159/115727/7042/7043	18
WP4630	Measles virus infection	9/676	117/5963	0.926245326884575	0.999999929473691	0.850202369188158	10332/3310/3552/3553/3559/3569/8503/6772/7097	9
WP2447	Amyotrophic lateral sclerosis (ALS)	2/676	36/5963	0.926936362309348	0.999999929473691	0.850202369188158	834/4741	2
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	2/676	36/5963	0.926936362309348	0.999999929473691	0.850202369188158	3488/5163	2
WP623	Oxidative phosphorylation	2/676	36/5963	0.926936362309348	0.999999929473691	0.850202369188158	3002/56901	2
WP2272	Pathogenic Escherichia coli infection	3/676	49/5963	0.927934878081465	0.999999929473691	0.850202369188158	9076/23643/347733	3
WP2637	Interleukin-1 (IL-1) structural pathway	3/676	49/5963	0.927934878081465	0.999999929473691	0.850202369188158	3552/3554/3556	3
WP363	Wnt signaling pathway	3/676	49/5963	0.927934878081465	0.999999929473691	0.850202369188158	2697/4920/7010	3
WP4482	Vitamin D in inflammatory diseases	1/676	22/5963	0.929494602539836	0.999999929473691	0.850202369188158	3569	1
WP712	Estrogen signaling pathway	1/676	22/5963	0.929494602539836	0.999999929473691	0.850202369188158	2099	1
WP4932	7q11.23 copy number variation syndrome	6/676	86/5963	0.935836846992601	0.999999929473691	0.850202369188158	9076/2199/2200/3084/9246/7472	6
WP3982	miRNA regulation of p53 pathway in prostate cancer	1/676	23/5963	0.937517098530927	0.999999929473691	0.850202369188158	5054	1
WP5064	7-oxo-C and 7-beta-HC pathways	1/676	23/5963	0.937517098530927	0.999999929473691	0.850202369188158	3290	1
WP2037	Prolactin signaling pathway	5/676	75/5963	0.938279724595131	0.999999929473691	0.850202369188158	4843/6196/8651/9021/6772	5
WP3286	Copper homeostasis	3/676	51/5963	0.939425033174265	0.999999929473691	0.850202369188158	4494/26872/79689	3
WP500	Glycogen synthesis and degradation	2/676	38/5963	0.940014252171706	0.999999929473691	0.850202369188158	3101/5255	2
WP4906	3q29 copy number variation syndrome	3/676	52/5963	0.944512043550195	0.999999929473691	0.850202369188158	3091/8503/7018	3
WP127	IL-5 signaling pathway	2/676	39/5963	0.945688411847496	0.999999929473691	0.850202369188158	1439/6772	2
WP534	Glycolysis and gluconeogenesis	2/676	39/5963	0.945688411847496	0.999999929473691	0.850202369188158	3101/6515	2
WP585	Interferon type I signaling pathways	3/676	53/5963	0.949200182742056	0.999999929473691	0.850202369188158	8651/9021/6772	3
WP4549	Fragile X syndrome	7/676	101/5963	0.949811811908164	0.999999929473691	0.850202369188158	816/80852/9456/4131/4915/5163/23236	7
WP2355	Corticotropin-releasing hormone signaling pathway	5/676	78/5963	0.950655489976845	0.999999929473691	0.850202369188158	2354/8061/2697/4846/7020	5
WP3965	Lipid metabolism pathway	1/676	25/5963	0.950930608920415	0.999999929473691	0.850202369188158	5346	1
WP314	Fas ligand pathway and stress induction of heat shock proteins	2/676	41/5963	0.955540237523762	0.999999929473691	0.850202369188158	3552/8767	2
WP1422	Sphingolipid pathway	1/676	26/5963	0.956516817807212	0.999999929473691	0.850202369188158	8877	1
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	2/676	42/5963	0.959801186465564	0.999999929473691	0.850202369188158	6347/3569	2
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	2/676	42/5963	0.959801186465564	0.999999929473691	0.850202369188158	7042/7043	2
WP2525	Trans-sulfuration and one-carbon metabolism	1/676	27/5963	0.961467909463322	0.999999929473691	0.850202369188158	29968	1
WP3869	Cannabinoid receptor signaling	1/676	27/5963	0.961467909463322	0.999999929473691	0.850202369188158	1543	1
WP3996	Ethanol effects on histone modifications	1/676	27/5963	0.961467909463322	0.999999929473691	0.850202369188158	8854	1
WP4204	Tumor suppressor activity of SMARCB1	1/676	27/5963	0.961467909463322	0.999999929473691	0.850202369188158	2737	1
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	4/676	70/5963	0.964744679043591	0.999999929473691	0.850202369188158	9423/5743/7042/7043	4
WP2583	T cell receptor and co-stimulatory signaling	1/676	28/5963	0.965855997940882	0.999999929473691	0.850202369188158	5163	1
WP5038	Mitochondrial immune response to SARS-CoV-2	1/676	28/5963	0.965855997940882	0.999999929473691	0.850202369188158	1514	1
WP673	ErbB signaling pathway	5/676	83/5963	0.966368756622838	0.999999929473691	0.850202369188158	816/3084/145957/8503/399694	5
WP2038	Microtubule cytoskeleton regulation	2/676	44/5963	0.967178441618254	0.999999929473691	0.850202369188158	2151/4131	2
WP410	Exercise-induced circadian regulation	2/676	44/5963	0.967178441618254	0.999999929473691	0.850202369188158	1051/50486	2
WP4255	Non-small cell lung cancer	4/676	71/5963	0.967566764210825	0.999999929473691	0.850202369188158	1381/1382/5163/8503	4
WP5205	CLOCKED CONTROLLED AUTOPHAGY IN BONE METABOLISM	4/676	71/5963	0.967566764210825	0.999999929473691	0.850202369188158	115908/1513/3569/7474	4
WP3680	Physico-chemical features and toxicity-associated pathways	3/676	58/5963	0.967581803634826	0.999999929473691	0.850202369188158	2335/11211/4741	3
WP4659	Gastrin signaling pathway	7/676	108/5963	0.968996787850638	0.999999929473691	0.850202369188158	9076/3067/4316/8503/5743/5054/7032	7
WP1601	Fluoropyrimidine activity	1/676	29/5963	0.969745019910884	0.999999929473691	0.850202369188158	1890	1
WP183	Proteasome degradation	3/676	59/5963	0.970410319637897	0.999999929473691	0.850202369188158	3458/5698/7345	3
WP304	Kit receptor signaling pathway	3/676	59/5963	0.970410319637897	0.999999929473691	0.850202369188158	6615/8651/6772	3
WP4321	Thermogenesis	6/676	98/5963	0.972957753637601	0.999999929473691	0.850202369188158	2180/2182/126129/9586/5346/6196	6
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	9/676	134/5963	0.974444750434404	0.999999929473691	0.850202369188158	249/55816/4688/4776/4915/399694/6696/6772/6853	9
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	1/676	31/5963	0.97624617569297	0.999999929473691	0.850202369188158	4776	1
WP3594	Circadian rhythm genes	11/676	159/5963	0.977932897773542	0.999999929473691	0.850202369188158	134/56938/2155/9456/3569/10135/22871/4843/4887/60675/5054	11
WP3995	Prion disease pathway	1/676	32/5963	0.978953118584331	0.999999929473691	0.850202369188158	6688	1
WP3998	Prader-Willi and Angelman syndrome	1/676	32/5963	0.978953118584331	0.999999929473691	0.850202369188158	4948	1
WP4396	Nonalcoholic fatty liver disease	9/676	137/5963	0.979066250117437	0.999999929473691	0.850202369188158	6347/84701/3552/3553/3569/56901/8503/9021/7494	9
WP4874	CAMKK2 pathway	1/676	33/5963	0.981351987550271	0.999999929473691	0.850202369188158	3383	1
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	1/676	33/5963	0.981351987550271	0.999999929473691	0.850202369188158	6772	1
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	3/676	64/5963	0.981377723187812	0.999999929473691	0.850202369188158	23236/6772/7253	3
WP2059	Alzheimer's disease and miRNA effects	17/676	229/5963	0.982393926702253	0.999999929473691	0.850202369188158	1139/11211/2906/3552/3553/3569/4023/407024/4843/8503/23236/5743/6622/347733/7472/7474/7494	17
WP313	Hepatocyte growth factor receptor signaling	1/676	34/5963	0.983477798075738	0.999999929473691	0.850202369188158	3082	1
WP4949	16p11.2 proximal deletion syndrome	3/676	67/5963	0.985963818834802	0.999999929473691	0.850202369188158	253982/2099/653808	3
WP2795	Cardiac hypertrophic response	2/676	53/5963	0.987055672421232	0.999999929473691	0.850202369188158	2247/3084	2
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	2/676	53/5963	0.987055672421232	0.999999929473691	0.850202369188158	3627/3458	2
WP4205	MET in type 1 papillary renal cell carcinoma	2/676	53/5963	0.987055672421232	0.999999929473691	0.850202369188158	3082/8503	2
WP2516	ATM signaling pathway	1/676	37/5963	0.988510067178535	0.999999929473691	0.850202369188158	8120	1
WP4148	Splicing factor NOVA regulated synaptic proteins	1/676	37/5963	0.988510067178535	0.999999929473691	0.850202369188158	2898	1
WP4666	Hepatitis B infection	8/676	134/5963	0.988709757650243	0.999999929473691	0.850202369188158	9586/3569/4776/8503/6772/7042/7043/7097	8
WP5124	Alzheimer's disease	16/676	226/5963	0.988774013939572	0.999999929473691	0.850202369188158	1139/11211/2906/3552/3553/3569/4023/4843/8503/23236/5743/6622/347733/7472/7474/7494	16
WP2857	Mesodermal commitment pathway	7/676	122/5963	0.988885054814068	0.999999929473691	0.850202369188158	2296/3624/10637/4211/154091/6615/64321	7
WP35	G protein signaling pathways	4/676	85/5963	0.990368225083099	0.999999929473691	0.850202369188158	2769/2791/51764/5142	4
WP3584	MECP2 and associated Rett syndrome	2/676	56/5963	0.9905606011396	0.999999929473691	0.850202369188158	2247/6890	2
WP5085	Vasopressin-regulated water reabsorption	1/676	39/5963	0.990982142592842	0.999999929473691	0.850202369188158	9586	1
WP4263	Pancreatic adenocarcinoma pathway	4/676	87/5963	0.991952323258148	0.999999929473691	0.850202369188158	8503/6772/7042/7043	4
WP5072	Modulators of TCR signaling and T cell activation	2/676	59/5963	0.993133055478175	0.999999929473691	0.850202369188158	3937/8651	2
WP4155	Endometrial cancer	2/676	61/5963	0.994452412427245	0.999999929473691	0.850202369188158	2247/8503	2
WP481	Insulin signaling	9/676	156/5963	0.994507919700293	0.999999929473691	0.850202369188158	30846/8503/57381/6196/10110/8651/9021/6812/7494	9
WP437	EGF/EGFR signaling pathway	9/676	157/5963	0.994898182285886	0.999999929473691	0.850202369188158	54206/2354/2697/4846/7837/6196/6772/6812/7291	9
WP4861	Endoplasmic reticulum stress response in coronavirus infection	1/676	44/5963	0.99508070618058	0.999999929473691	0.850202369188158	7494	1
WP4685	Melanoma	2/676	63/5963	0.995522454593073	0.999999929473691	0.850202369188158	3791/8503	2
WP3915	Angiopoietin-like protein 8 regulatory pathway	6/676	125/5963	0.996884118687244	0.999999929473691	0.850202369188158	1555/4023/8503/6196/6567/7068	6
WP254	Apoptosis	3/676	84/5963	0.997328368770507	0.999999929473691	0.850202369188158	834/3002/8739	3
WP4656	Joubert syndrome	2/676	71/5963	0.998115832484051	0.999999929473691	0.850202369188158	27077/6469	2
WP231	TNF-alpha signaling pathway	3/676	92/5963	0.998809237752076	0.999999929473691	0.850202369188158	6347/3569/6401	3
WP3651	Pathways affected in adenoid cystic carcinoma	1/676	58/5963	0.999101161363656	0.999999929473691	0.850202369188158	4603	1
WP2261	Glioblastoma signaling pathways	2/676	82/5963	0.999437580292428	0.999999929473691	0.850202369188158	54206/5159	2
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	1/676	66/5963	0.999660370672657	0.999999929473691	0.850202369188158	4023	1
WP4536	Genes related to primary cilium development (based on CRISPR)	2/676	88/5963	0.999711388538958	0.999999929473691	0.850202369188158	27077/23552	2
WP4674	Head and neck squamous cell carcinoma	1/676	72/5963	0.999836469995233	0.999999929473691	0.850202369188158	7015	1
WP179	Cell cycle	3/676	115/5963	0.999891559066308	0.999999929473691	0.850202369188158	994/7042/7043	3
WP4022	Pyrimidine metabolism	1/676	79/5963	0.999930360821239	0.999999929473691	0.850202369188158	1890	1
WP138	Androgen receptor signaling pathway	1/676	85/5963	0.999966526609247	0.999999929473691	0.850202369188158	354	1
WP2446	Retinoblastoma gene in cancer	1/676	86/5963	0.999970376220024	0.999999929473691	0.850202369188158	994	1
WP477	Cytoplasmic ribosomal proteins	1/676	86/5963	0.999970376220024	0.999999929473691	0.850202369188158	6196	1
WP23	B cell receptor signaling pathway	1/676	96/5963	0.999991279941646	0.999999929473691	0.850202369188158	1380	1
WP4803	Ciliopathies	3/676	139/5963	0.999991849822658	0.999999929473691	0.850202369188158	27077/10309/2737	3
WP4352	Ciliary landscape	4/676	201/5963	0.999999929473691	0.999999929473691	0.850202369188158	3934/4741/7020/7022	4
